US$ 29.56
semaglutide in leg Injecting Semaglutide: A Guide to Injection Sites and Technique Semaglutide and Leg Cramps: Causes,
Description
PMC 4410974

My take on the FDA GLP-1 announcement that they intend to Take Action Against Non-FDA-Approved GLP-1 Drugs. Its clearly been sparked by Himss actions

Ozempic and Rybelsus are approved for long-term use in managing type 2 diabetes and related conditions

Glucagon-like peptide-1 (GLP-1) receptor agonists have gained attention primarily as weight-loss tools, but emerging clinical evidence suggests their therapeutic range extends well beyond the scale
The interplay of these factors means that skin changes during Ozempic therapy are likely multifactorial rather than attributable to a single cause, and individual susceptibility varies considerably based on personal physiology, lifestyle, and pre-existing skin conditions
